CN Stock MarketDetailed Quotes

300122 Chongqing Zhifei Biological Products

Watchlist
  • 30.69
  • -0.36-1.16%
Trading Jun 7 14:48 CST
73.47BMarket Cap9.80P/E (TTM)

Chongqing Zhifei Biological Products Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
2.00%11.4B
38.30%52.92B
41.15%39.27B
33.19%24.45B
26.37%11.17B
24.83%38.26B
27.46%27.82B
39.34%18.35B
125.16%8.84B
101.79%30.65B
Operating revenue
2.00%11.4B
38.30%52.92B
41.15%39.27B
33.19%24.45B
26.37%11.17B
24.83%38.26B
27.46%27.82B
39.34%18.35B
125.16%8.84B
101.79%30.65B
Other operating revenue
----
5.86%4.08M
----
18.55%2.55M
----
-83.58%3.85M
----
-84.84%2.15M
----
-31.47%23.46M
Total operating cost
8.45%9.32B
48.35%43.09B
47.80%31.15B
38.69%19.16B
32.19%8.6B
57.31%29.05B
78.26%21.07B
107.35%13.82B
135.96%6.5B
65.18%18.47B
Operating cost
8.22%8.43B
52.29%38.67B
51.56%28.17B
41.00%17.22B
32.79%7.79B
62.56%25.4B
85.16%18.59B
122.40%12.21B
152.91%5.86B
68.56%15.62B
Operating tax surcharges
0.96%50.14M
34.87%238.75M
37.39%175.03M
31.81%111.93M
35.60%49.66M
30.90%177.02M
30.75%127.39M
36.93%84.92M
123.51%36.63M
90.50%135.23M
Operating expense
10.83%495.13M
24.04%2.77B
25.56%1.84B
24.71%1.19B
23.18%446.75M
21.82%2.24B
19.91%1.47B
22.18%950.67M
33.36%362.68M
53.22%1.83B
Administration expense
38.95%110.95M
5.05%393.03M
-0.85%273.5M
6.87%183.49M
10.80%79.85M
24.63%374.13M
37.30%275.84M
33.03%171.7M
26.19%72.07M
41.43%300.2M
Financial expense
-69.57%5.96M
242.20%47.22M
379.40%35.21M
217.72%21.99M
178.72%19.6M
-36.77%13.8M
-62.63%7.34M
-82.34%6.92M
-76.84%7.03M
-83.39%21.82M
-Interest expense (Financial expense)
15.25%24.48M
51.98%81M
37.45%57.61M
41.25%39.66M
138.10%21.24M
-5.07%53.3M
-22.39%41.91M
-43.40%28.08M
-68.22%8.92M
-55.84%56.14M
-Interest Income (Financial expense)
-125.95%-29.66M
-47.40%-67.94M
-36.55%-47.1M
-44.64%-31.03M
-7.40%-13.13M
25.01%-46.09M
20.18%-34.49M
-33.32%-21.45M
-285.63%-12.22M
-447.32%-61.47M
Research and development
9.41%234.08M
13.38%968.47M
6.76%648.54M
12.68%436.88M
32.98%213.96M
54.56%854.16M
152.77%607.5M
138.26%387.72M
161.12%160.89M
84.42%552.63M
Credit Impairment Loss
-126.58%-340.79M
16.32%-352.71M
-122.44%-567.84M
-58.63%-316.98M
-11.84%-150.41M
-120.78%-421.51M
-59.90%-255.28M
-78.87%-199.83M
-111.69%-134.48M
-129.39%-190.92M
Asset Impairment Loss
97.03%-1.03M
-186.58%-311.99M
-264.91%-115.14M
-620.30%-62.79M
-223.84%-34.59M
-17.67%-108.87M
-567.91%-31.55M
-114.80%-8.72M
4,321.50%27.93M
-93.58%-92.52M
Other net revenue
-87.50%-335.67M
1.28%-449.97M
-109.96%-489.7M
-93.03%-317.11M
-161.21%-179.02M
-145.10%-455.79M
-75.71%-233.24M
-56.25%-164.28M
-13.19%-68.53M
-61.03%-185.96M
Fair value change income
----
----
----
----
----
----
----
----
----
208.06%14.4M
Invest income
----
----
----
----
----
----
----
----
----
-2,763.82%-20.03M
Asset deal income
----
618,276.31%41.37M
280,967.56%43.05M
281,852.30%43.19M
--41.78K
-82.90%6.69K
-14.47%15.32K
-14.47%15.32K
----
956.60%39.13K
Other revenue
3.78%6.16M
132.43%173.36M
180.39%150.23M
-55.98%19.48M
-84.40%5.93M
-27.63%74.59M
38.41%53.58M
166.73%44.25M
1,030.69%38.02M
266.51%103.07M
Operating profit
-27.54%1.74B
7.02%9.37B
17.18%7.64B
13.57%4.97B
5.62%2.4B
-27.01%8.76B
-34.01%6.52B
-31.69%4.37B
104.45%2.27B
208.08%12B
Add:Non operating Income
83.63%18.52K
-44.80%337.69K
-89.19%15.96K
-91.29%11.95K
681.73%10.09K
230.76%611.76K
73.93%147.64K
191.58%137.18K
-39.42%1.29K
41.77%184.96K
Less:Non operating expense
-36.55%2.92M
-23.18%31.48M
-50.39%16.79M
-75.46%5.12M
-27.15%4.6M
-40.69%40.98M
-30.89%33.84M
-16.76%20.88M
-27.68%6.31M
67.96%69.1M
Total profit
-27.53%1.73B
7.16%9.34B
17.53%7.62B
13.99%4.96B
5.71%2.39B
-26.93%8.72B
-34.02%6.48B
-31.75%4.35B
105.49%2.26B
209.57%11.93B
Less:Income tax cost
-23.38%276.02M
7.92%1.27B
24.37%1.09B
12.55%702.41M
5.89%360.26M
-31.55%1.18B
-38.42%875.41M
-29.69%624.11M
108.63%340.22M
211.63%1.72B
Net profit
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
209.23%10.21B
Net profit from continuing operation
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
209.23%10.21B
Net profit of parent company owners
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
209.23%10.21B
Earning per share
Basic earning per share
-28.07%0.609
7.04%3.3624
16.47%2.721
14.24%1.775
-29.54%0.8467
-50.77%3.1412
-55.52%2.3363
-54.72%1.5538
104.93%1.2017
209.23%6.3803
Diluted earning per share
-28.07%0.609
7.04%3.3624
16.47%2.721
14.24%1.775
-29.54%0.8467
-50.77%3.1412
-55.52%2.3363
-54.72%1.5538
104.93%1.2017
209.23%6.3803
Other composite income
Total composite income
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
209.23%10.21B
Total composite income of parent company owners
-28.26%1.46B
7.04%8.07B
16.46%6.53B
14.24%4.26B
5.68%2.03B
-26.15%7.54B
-33.28%5.61B
-32.08%3.73B
104.95%1.92B
209.23%10.21B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 2.00%11.4B38.30%52.92B41.15%39.27B33.19%24.45B26.37%11.17B24.83%38.26B27.46%27.82B39.34%18.35B125.16%8.84B101.79%30.65B
Operating revenue 2.00%11.4B38.30%52.92B41.15%39.27B33.19%24.45B26.37%11.17B24.83%38.26B27.46%27.82B39.34%18.35B125.16%8.84B101.79%30.65B
Other operating revenue ----5.86%4.08M----18.55%2.55M-----83.58%3.85M-----84.84%2.15M-----31.47%23.46M
Total operating cost 8.45%9.32B48.35%43.09B47.80%31.15B38.69%19.16B32.19%8.6B57.31%29.05B78.26%21.07B107.35%13.82B135.96%6.5B65.18%18.47B
Operating cost 8.22%8.43B52.29%38.67B51.56%28.17B41.00%17.22B32.79%7.79B62.56%25.4B85.16%18.59B122.40%12.21B152.91%5.86B68.56%15.62B
Operating tax surcharges 0.96%50.14M34.87%238.75M37.39%175.03M31.81%111.93M35.60%49.66M30.90%177.02M30.75%127.39M36.93%84.92M123.51%36.63M90.50%135.23M
Operating expense 10.83%495.13M24.04%2.77B25.56%1.84B24.71%1.19B23.18%446.75M21.82%2.24B19.91%1.47B22.18%950.67M33.36%362.68M53.22%1.83B
Administration expense 38.95%110.95M5.05%393.03M-0.85%273.5M6.87%183.49M10.80%79.85M24.63%374.13M37.30%275.84M33.03%171.7M26.19%72.07M41.43%300.2M
Financial expense -69.57%5.96M242.20%47.22M379.40%35.21M217.72%21.99M178.72%19.6M-36.77%13.8M-62.63%7.34M-82.34%6.92M-76.84%7.03M-83.39%21.82M
-Interest expense (Financial expense) 15.25%24.48M51.98%81M37.45%57.61M41.25%39.66M138.10%21.24M-5.07%53.3M-22.39%41.91M-43.40%28.08M-68.22%8.92M-55.84%56.14M
-Interest Income (Financial expense) -125.95%-29.66M-47.40%-67.94M-36.55%-47.1M-44.64%-31.03M-7.40%-13.13M25.01%-46.09M20.18%-34.49M-33.32%-21.45M-285.63%-12.22M-447.32%-61.47M
Research and development 9.41%234.08M13.38%968.47M6.76%648.54M12.68%436.88M32.98%213.96M54.56%854.16M152.77%607.5M138.26%387.72M161.12%160.89M84.42%552.63M
Credit Impairment Loss -126.58%-340.79M16.32%-352.71M-122.44%-567.84M-58.63%-316.98M-11.84%-150.41M-120.78%-421.51M-59.90%-255.28M-78.87%-199.83M-111.69%-134.48M-129.39%-190.92M
Asset Impairment Loss 97.03%-1.03M-186.58%-311.99M-264.91%-115.14M-620.30%-62.79M-223.84%-34.59M-17.67%-108.87M-567.91%-31.55M-114.80%-8.72M4,321.50%27.93M-93.58%-92.52M
Other net revenue -87.50%-335.67M1.28%-449.97M-109.96%-489.7M-93.03%-317.11M-161.21%-179.02M-145.10%-455.79M-75.71%-233.24M-56.25%-164.28M-13.19%-68.53M-61.03%-185.96M
Fair value change income ------------------------------------208.06%14.4M
Invest income -------------------------------------2,763.82%-20.03M
Asset deal income ----618,276.31%41.37M280,967.56%43.05M281,852.30%43.19M--41.78K-82.90%6.69K-14.47%15.32K-14.47%15.32K----956.60%39.13K
Other revenue 3.78%6.16M132.43%173.36M180.39%150.23M-55.98%19.48M-84.40%5.93M-27.63%74.59M38.41%53.58M166.73%44.25M1,030.69%38.02M266.51%103.07M
Operating profit -27.54%1.74B7.02%9.37B17.18%7.64B13.57%4.97B5.62%2.4B-27.01%8.76B-34.01%6.52B-31.69%4.37B104.45%2.27B208.08%12B
Add:Non operating Income 83.63%18.52K-44.80%337.69K-89.19%15.96K-91.29%11.95K681.73%10.09K230.76%611.76K73.93%147.64K191.58%137.18K-39.42%1.29K41.77%184.96K
Less:Non operating expense -36.55%2.92M-23.18%31.48M-50.39%16.79M-75.46%5.12M-27.15%4.6M-40.69%40.98M-30.89%33.84M-16.76%20.88M-27.68%6.31M67.96%69.1M
Total profit -27.53%1.73B7.16%9.34B17.53%7.62B13.99%4.96B5.71%2.39B-26.93%8.72B-34.02%6.48B-31.75%4.35B105.49%2.26B209.57%11.93B
Less:Income tax cost -23.38%276.02M7.92%1.27B24.37%1.09B12.55%702.41M5.89%360.26M-31.55%1.18B-38.42%875.41M-29.69%624.11M108.63%340.22M211.63%1.72B
Net profit -28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B209.23%10.21B
Net profit from continuing operation -28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B209.23%10.21B
Net profit of parent company owners -28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B209.23%10.21B
Earning per share
Basic earning per share -28.07%0.6097.04%3.362416.47%2.72114.24%1.775-29.54%0.8467-50.77%3.1412-55.52%2.3363-54.72%1.5538104.93%1.2017209.23%6.3803
Diluted earning per share -28.07%0.6097.04%3.362416.47%2.72114.24%1.775-29.54%0.8467-50.77%3.1412-55.52%2.3363-54.72%1.5538104.93%1.2017209.23%6.3803
Other composite income
Total composite income -28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B209.23%10.21B
Total composite income of parent company owners -28.26%1.46B7.04%8.07B16.46%6.53B14.24%4.26B5.68%2.03B-26.15%7.54B-33.28%5.61B-32.08%3.73B104.95%1.92B209.23%10.21B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg